SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-003862
Filing Date
2019-05-02
Accepted
2019-05-02 16:16:27
Documents
74
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20190331x10q.htm 10-Q 1389780
2 EX-10.1 idra-20190331ex101701efb.htm EX-10.1 420690
3 EX-31.1 idra-20190331ex31147566e.htm EX-31.1 18373
4 EX-31.2 idra-20190331ex312e8ca8e.htm EX-31.2 18882
5 EX-32.1 idra-20190331ex32151297e.htm EX-32.1 7936
6 EX-32.2 idra-20190331ex3220d5ae4.htm EX-32.2 8358
7 GRAPHIC idra20190331x10q001.jpg GRAPHIC 14972
8 GRAPHIC idra20190331x10q002.jpg GRAPHIC 7572
9 GRAPHIC idra20190331x10q003.jpg GRAPHIC 8010
10 GRAPHIC idra20190331x10q004.jpg GRAPHIC 7470
11 GRAPHIC idra20190331x10q005.jpg GRAPHIC 9393
  Complete submission text file 0001558370-19-003862.txt   5888683

Data Files

Seq Description Document Type Size
12 EX-101.INS idra-20190331.xml EX-101.INS 1123220
13 EX-101.SCH idra-20190331.xsd EX-101.SCH 41510
14 EX-101.CAL idra-20190331_cal.xml EX-101.CAL 41005
15 EX-101.DEF idra-20190331_def.xml EX-101.DEF 159599
16 EX-101.LAB idra-20190331_lab.xml EX-101.LAB 341735
17 EX-101.PRE idra-20190331_pre.xml EX-101.PRE 288561
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 19792102
SIC: 2836 Biological Products, (No Diagnostic Substances)